Trial Profile

Effect of Dexmedetomidine on Pacemaker Function Following Cardiac Surgery

Status: Withdrawn prior to enrolment

Phase of Trial: Phase IV

Latest Information Update: 02 Apr 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dexmedetomidine (Primary)
Indications Cancer pain; Pain; Sedation
Focus Pharmacodynamics

Most Recent Events

27 Mar 2019 Planned End Date changed from 1 Dec 2019 to 11 Mar 2019.
27 Mar 2019 Planned primary completion date changed from 1 Dec 2019 to 11 Mar 2019.
27 Mar 2019 Status changed from recruiting to withdrawn prior to enrolment.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com